Local Peloid Therapy: Participants will receive local peloid therapy applied externally over the temporomandibular joint region and adjacent masticatory muscles. The treatment will be delivered as 10 sessions over 2 weeks, with 5 sessions per week. Each session will last 20 minutes. Peloid therapy will be administered by a trained investigator according to the study protocol.
Study summary
This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks. Pain and functional outcomes will be measured at baseline and at the end of treatment using validated clinical scales, including the Jaw Functional Limitation Scale-8, visual analog scale pain scores, Fonseca index, maximum mouth opening, and secondary otalgia assessment.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Age between 18 and 65 years
* Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
* Presence of TMJ-related pain for at least 4 weeks
* Baseline pain intensity ≥3 on a 0-10 visual analog scale
* Ability to provide written informed consent
Exclusion Criteria:
* History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
* Previous temporomandibular joint surgery
* Presence of systemic inflammatory rheumatologic disease
* Pregnancy
* Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site
* Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months
* Any clinical or behavioral condition that may interfere with study compliance
Primary outcome measure(s)
Change in Jaw Function Score at Week 2 — Baseline and Week 2 Jaw function will be assessed using the Jaw Functional Limitation Scale-8 (JFLS-8). This is a patient-reported questionnaire that measures limitation in jaw activities such as chewing, speaking, and mouth opening. The total score ranges from 0 to 10, where 0 indicates no functional limitation and 10 indicates the highest level of limitation. The primary outcome will be the change in JFLS-8 total score from baseline to Week 2.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.